Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 36Prostatic Neoplasms 27Carcinoma, Non-Small-Cell Lung 14Lymphoma 13Rectal Neoplasms 11Lung Neoplasms 11Head and Neck Neoplasms 11Recurrence 10Neoplasms 10Neoplasm Metastasis 9Carcinoma, Hepatocellular 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 8Uterine Cervical Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Leukemia 7Central Nervous System Neoplasms 7Brain Neoplasms 7Multiple Myeloma 6Hyperthermia 6Carcinoma, Intraductal, Noninfiltrating 6Lymphoma, Follicular 5Hodgkin Disease 5Glioblastoma 5Dendritic Cell Sarcoma, Interdigitating 5Congenital Abnormalities 5Colorectal Neoplasms 5

Interventions

Radiotherapy 1HMPL-013 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × MSS Metastatic Colorectal Cancer × Radiotherapy × Clear all
NCT06613113 2024-09-25

Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.

Ningbo Medical Center Lihuili Hospital

Phase NA Recruiting
30 enrolled
Gastrointestinal

MSS Metastatic Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡